BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX7353 for the Treatment of Hereditary Angioedema
May 13, 2015 at 06:58 AM EDT
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the initiation of a Phase 1 clinical trial to evaluate the safety, ...